The SFDA approved Amplifai Health's software as a medical device for diabetic foot screening. Multicentre findings in Saudi Arabia confirm that AI-powered thermal imaging identifies early risk patterns in real-world clinics. This regulatory win validates the tool's clinical utility. Practitioners can now deploy automated thermal screening to prevent diabetic amputations.